Dr. Reddy's Labs Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Jun 9, 2025 · CIK: 1135951
| Field | Detail |
|---|---|
| Company | Dr Reddys Laboratories Ltd (RDY) |
| Form Type | 6-K |
| Filed Date | Jun 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, regulatory-update
TL;DR
DRL filed a 6-K, standard foreign issuer update. Nothing major.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on June 9, 2025, reporting information as of June 7, 2025. The filing indicates the company is a foreign private issuer and will file annual reports under Form 20-F. The document is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Why It Matters
This filing provides routine updates for investors and regulators regarding Dr. Reddy's Laboratories' status as a foreign private issuer and its reporting obligations.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain material new financial or operational information.
Key Players & Entities
- Dr. Reddy's Laboratories Limited (company) — Registrant
- 0001575872-25-000395 (accession_number) — Filing identifier
- 20250609 (date) — Filing date
- 20250607 (date) — Period of report
- 1-15182 (sec_file_number) — SEC file number
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Who is the filer?
The filer is Dr. Reddy's Laboratories Limited.
When was this report filed?
The report was filed on June 9, 2025.
What period does this report cover?
The report is conformed as of June 7, 2025.
Does Dr. Reddy's Laboratories file annual reports under Form 20-F or 40-F?
Dr. Reddy's Laboratories Limited indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 9, 2025 regarding DR REDDYS LABORATORIES LTD (RDY).